Cas no 1269292-02-5 (3-bromo-2-methyl-5-nitrobenzoic acid)

3-bromo-2-methyl-5-nitrobenzoic acid is a versatile compound with a distinct structural profile. It offers enhanced reactivity due to the presence of the nitro and bromo substituents, which are known to facilitate electrophilic aromatic substitution reactions. This compound's unique properties make it a valuable tool in organic synthesis, particularly for constructing complex molecular frameworks. Its stability and availability make it an attractive choice for researchers seeking reliable and efficient synthetic intermediates.
3-bromo-2-methyl-5-nitrobenzoic acid structure
1269292-02-5 structure
Product Name:3-bromo-2-methyl-5-nitrobenzoic acid
CAS No:1269292-02-5
MF:C8H6BrNO4
MW:260.041541576386
MDL:MFCD20275367
CID:3165309
PubChem ID:53418770
Update Time:2025-06-18

3-bromo-2-methyl-5-nitrobenzoic acid Chemical and Physical Properties

Names and Identifiers

    • 3-bromo-2-methyl-5-nitrobenzoic acid
    • MDL: MFCD20275367
    • Inchi: 1S/C8H6BrNO4/c1-4-6(8(11)12)2-5(10(13)14)3-7(4)9/h2-3H,1H3,(H,11,12)
    • InChI Key: QQHDTQSCWLYJHU-UHFFFAOYSA-N
    • SMILES: BrC1=CC(=CC(C(=O)O)=C1C)[N+](=O)[O-]

3-bromo-2-methyl-5-nitrobenzoic acid Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
TRC
B813108-10mg
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5
10mg
$ 50.00 2022-04-01
TRC
B813108-50mg
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5
50mg
$ 160.00 2022-04-01
TRC
B813108-100mg
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5
100mg
$ 230.00 2022-04-01
Alichem
A010011752-250mg
3-Bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 97%
250mg
504.00 USD 2021-07-06
Alichem
A010011752-500mg
3-Bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 97%
500mg
847.60 USD 2021-07-06
Alichem
A010011752-1g
3-Bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 97%
1g
1,490.00 USD 2021-07-06
Enamine
EN300-203844-0.05g
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 95%
0.05g
$157.0 2023-09-16
Enamine
EN300-203844-0.1g
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 95%
0.1g
$235.0 2023-09-16
Enamine
EN300-203844-0.25g
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 95%
0.25g
$335.0 2023-09-16
Enamine
EN300-203844-0.5g
3-bromo-2-methyl-5-nitrobenzoic acid
1269292-02-5 95%
0.5g
$528.0 2023-09-16

Additional information on 3-bromo-2-methyl-5-nitrobenzoic acid

Introduction to 3-bromo-2-methyl-5-nitrobenzoic acid (CAS No. 1269292-02-5)

3-bromo-2-methyl-5-nitrobenzoic acid, identified by the Chemical Abstracts Service (CAS) number 1269292-02-5, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of nitroaromatic acids, characterized by the presence of a nitro group and a bromine substituent on a benzene ring, which is further modified by a methyl group. The structural features of 3-bromo-2-methyl-5-nitrobenzoic acid make it a versatile intermediate in synthetic chemistry, particularly in the development of novel bioactive molecules.

The nitro group in 3-bromo-2-methyl-5-nitrobenzoic acid is a key functional moiety that influences its reactivity and biological properties. Nitroaromatic compounds are well-documented for their role in various pharmacological applications, including antimicrobial, anti-inflammatory, and anticancer agents. The electron-withdrawing nature of the nitro group enhances the electrophilicity of the aromatic ring, making it susceptible to nucleophilic substitution reactions. This property is exploited in multi-step synthetic pathways to introduce additional functional groups or to construct more complex molecular architectures.

The bromine substituent at the 3-position of the benzene ring in 3-bromo-2-methyl-5-nitrobenzoic acid adds another layer of reactivity, enabling further derivatization through cross-coupling reactions such as Suzuki-Miyaura or Buchwald-Hartwig couplings. These reactions are pivotal in constructing biaryl structures, which are prevalent in many pharmacologically active compounds. The presence of both the nitro and bromine groups makes 3-bromo-2-methyl-5-nitrobenzoic acid a valuable building block for medicinal chemists seeking to develop innovative therapeutic agents.

The methyl group at the 2-position contributes to the steric and electronic environment of the benzene ring, influencing its interaction with biological targets. In drug design, subtle modifications at this position can significantly alter the binding affinity and selectivity of a compound. Recent studies have highlighted the importance of methyl-substituted aromatic compounds in modulating enzyme activity and receptor binding. For instance, derivatives of benzoic acids with methyl groups have been shown to exhibit potent inhibitory effects on various enzymes involved in metabolic pathways.

Recent advancements in computational chemistry and molecular modeling have further enhanced our understanding of how structural modifications in compounds like 3-bromo-2-methyl-5-nitrobenzoic acid affect their biological activity. These tools allow researchers to predict the binding modes of potential drug candidates with high precision, thereby accelerating the drug discovery process. The integration of experimental data with computational methods has led to more efficient synthesis strategies and improved yields of target compounds.

In addition to its synthetic utility, 3-bromo-2-methyl-5-nitrobenzoic acid has been explored in several preclinical studies for its potential therapeutic applications. The nitroaromatic scaffold is known for its ability to interact with biological macromolecules such as proteins and nucleic acids. Researchers have investigated its derivatives for their antimicrobial properties, particularly against resistant bacterial strains. The combination of bromine and nitro groups enhances its bioavailability and metabolic stability, making it an attractive candidate for further development.

The pharmaceutical industry continues to leverage natural product-inspired scaffolds to discover new drugs. Compounds derived from benzoic acid derivatives are among those that have shown promise in treating a variety of diseases. For example, modified benzoic acids have been reported to exhibit anti-inflammatory effects by inhibiting key pro-inflammatory cytokines. The structural diversity offered by compounds like 3-bromo-2-methyl-5-nitrobenzoic acid allows for extensive chemical manipulation, enabling the optimization of pharmacokinetic profiles and target engagement.

Another area where 3-bromo-2-methyl-5-nitrobenzoic acid finds application is in materials science. Nitroaromatic compounds are known for their photochemical properties, making them useful in organic electronics and optoelectronic devices. The ability to functionalize these compounds with various substituents allows for fine-tuning their electronic characteristics, which is crucial for developing advanced materials such as organic semiconductors and light-emitting diodes (OLEDs).

The synthesis of 3-bromo-2-methyl-5-nitrobenzoic acid typically involves multi-step organic reactions starting from commercially available precursors. The process often begins with nitration followed by bromination and methylation steps, each requiring careful control of reaction conditions to ensure high yield and purity. Advances in green chemistry principles have also influenced synthetic methodologies, leading to more sustainable approaches that minimize waste and hazardous byproducts.

In conclusion,3-bromo-2-methyl-5-nitrobenzoic acid (CAS No. 1269292-02-5) is a multifaceted compound with significant potential in pharmaceutical research and industrial applications. Its unique structural features enable diverse chemical modifications, making it a valuable intermediate for synthesizing bioactive molecules. The ongoing exploration of its derivatives continues to yield promising results in drug discovery and material science, underscoring its importance as a research tool.

Recommended suppliers
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Shanghai Jinhuan Chemical CO., LTD.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Jinhuan Chemical CO., LTD.
Essenoi Fine Chemical Co., Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinta Yudi Pharmaceutical Technology Co., Ltd.